SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy
Vasogen-- VAS on TSE
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
377 19 0 VSGN
Emcee:  caly Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
377Vasogen is not dead and buried, probably best performing stock on TSX over the pStephen O-12/20/2007
376<img src='http://us.i1.yimg.com/us.yimg.com/i/nt/ic/ut/bsc/warn16_1.gif&#Done, gone.-1/26/2007
375>>>You aren't getting it. You have no idea how to do stats do you? Pluvia-9/11/2006
374<i>not only are you off mark with that shot, but you're so far off youClarksterh-9/11/2006
373>>I understand the implicit putative MOA for their stat sig subgroup. But Pluvia-9/11/2006
372<i>Obviously damaged heart tissue seems to be key. Given VSGN's admissClarksterh-9/11/2006
371I suggest you read the data more carefully. ~ Remove prior heart attack from Pluvia-9/11/2006
370<i>They only split into classes II, III and IV basically.</i> They Clarksterh-9/7/2006
369I still don't understand. They only split into classes II, III and IV basiStephen O-9/7/2006
368<i>Doesn't it just mean that celacade did not work worth a damn with tClarksterh-9/7/2006
367Doesn't it just mean that celacade did not work worth a damn with the othersStephen O-9/7/2006
366<i>1. likely not data mining - BECAUSE 2. they were pre-determined subgrouClarksterh-9/7/2006
3651. likely not data mining - BECAUSE 2. they were pre-determined subgroups AND Pluvia-9/6/2006
364'Interesting new look at the CHF trial. Keep in mind that, although this looDone, gone.-9/4/2006
363<img src='http://www.novell.com/coolblogs/wp-content/uploads/2006/04/footDone, gone.-9/3/2006
362New Data from Vasogen's ACCLAIM Trial in Heart Failure Presented at World CoPluvia-9/3/2006
361Vasogen heart therapy cuts risk in 70 pct of patients Sun Sep 3, 2006 5:10am ET1Pluvia-9/3/2006
360Why bother? Matter of time before their remaining pennies run out and time foDone, gone.-7/16/2006
359For more discussion on Vasogen, check out the following links: Yahoo! messages.Jackboot27-7/15/2006
358Phase III Acclaim trial of the drug Celacade failed to meet its primary endpointDone, gone.-6/26/2006
357If Acclaim results are successful, I expect a gap up of $3 a shareStephen O-6/15/2006
356<i> I expect the share price to be at least $3.00 by September.</i> Done, gone.-6/15/2006
355Nice job, my "sixth sense" tells me you will win huge on this one IMODaiTN-6/15/2006
354<i>we remain on track to release the top-line results from the ACCLAIM triDone, gone.-6/14/2006
353LOL [graphic]russet-6/8/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News